Company intelligence / Profile preview

Medimaging Integrated Solution

Hsinchu, Taiwan

Ownership: Private
Development stage: Other

Overview

Medimaging Integrated Solution develops and commercially sells certified digital hand-held diagnostic scopes (Horus Scope series and related devices) and image-management/AI tools for telemedicine and point‑of‑care screening worldwide; it does not develop drugs and therefore has no traditional clinical trial pipeline, but its devices have obtained multiple regulatory clearances (TFDA, FDA 510(k), CE, NMPA/CFDA, PMDA, Thai FDA) for clinical use in ophthalmology, ENT, bronchoscopy, cystoscopy and wound care.[3][6][10][11]

Therapeutic areas: OtherPulmonologyOphthalmologyDermatology
Modalities: DeviceNon-pharmacological therapy
Industry: Medical Imaging

Partnerships

Bayer Taiwan G4A x H.Spectrum Innovation Program (innovation / acceleration collaboration)[3]

Beyond the preview

Go deeper on Medimaging Integrated Solution.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medimaging Integrated Solution.

Explore the full profile